Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,191.94 +22.08 (+1.89%)

Official Closing Price Updated: 7:00 PM EDT, Aug 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

XLV vs IYH: Which Healthcare ETF Wins on Cost and Yield? ↗

July 27, 2026

State Street's fund charges just 0.08% annually versus 0.38% for iShares, but the broader portfolio offers 100 holdings versus 60.

Via The Motley Fool

Topics ETFs

XLV vs FHLC: Which Healthcare ETF Fits Your Portfolio? ↗

July 27, 2026

State Street's concentrated 60-stock approach outpaced Fidelity's broader 365-holding fund over five years, though both charge identical 0.08% fees.

Via The Motley Fool

Topics ETFs

3 Quality Compounders to Own for Decades

July 27, 2026

A quality compounder is a business that not only sports durable competitive advantages but also builds on its success by consistently reinvesting its profits...

Via StockStory

Pharmaceuticals Stocks Q1 In Review: Ocular Therapeutix (NASDAQ:OCUL) Vs Peers

July 26, 2026

Let’s dig into the relative performance of Ocular Therapeutix (NASDAQ:OCUL) and its peers as we unravel the now-completed Q1 pharmaceuticals earnings season....

Via StockStory

Topics Artificial Intelligence Intellectual Property

Eli Lilly (NYSE:LLY): High-Growth Stock with Strong Technical and Fundamental Momentum ↗

July 25, 2026

Via Chartmill

Eli Lilly (NYSE:LLY) Shows Strong Growth and Breakout Technical Setup ↗

July 23, 2026

Via Chartmill

Spotting Winners: Corcept (NASDAQ:CORT) And Branded Pharmaceuticals Stocks In Q1

July 26, 2026

Let’s dig into the relative performance of Corcept (NASDAQ:CORT) and its peers as we unravel the now-completed Q1 branded pharmaceuticals earnings season. Lo...

Via StockStory

Topics Artificial Intelligence Intellectual Property

PINK vs. XLV: How Do These Two Health Care ETFs Match Up? ↗

July 26, 2026

PINK outperformed XLV by 8.7 percentage points over one year, but carries higher fees and volatility. XLV offers lower costs and a higher dividend yield for passive healthcare exposure.

Via The Motley Fool

Topics ETFs

Better Healthcare Sector ETF: Vanguard's Broad VHT vs. Invesco's Biotechnology-Focused IBBQ ↗

July 26, 2026

Vanguard's broad sector approach costs half as much and yields twice the dividend, while Invesco's biotech focus delivered stronger 1-year returns but with steeper downside risk.

Via The Motley Fool

Topics ETFs

Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio? ↗

July 26, 2026

PPH targets drugmakers exclusively with higher returns but steeper costs, while XLV diversifies across medical equipment and providers at a fraction of the fee.

Via The Motley Fool

Topics ETFs

10 Stocks Make Up 60% of This $220 Billion Vanguard ETF. Here's What That Means If the AI Trade Cracks. ↗

July 25, 2026

How diversified is a 147-stock fund when 10 names hold 60% of the money?

Via The Motley Fool

Topics Artificial Intelligence ETFs

Eli Lilly, Dell Among Stocks To Watch As Market Leadership Shifts ↗

July 25, 2026

Via Investor's Business Daily

Topics Artificial Intelligence

Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors? ↗

July 24, 2026

Novo Nordisk is accusing Eli Lilly of deceptive advertising about GLP-1 drugs.

Via The Motley Fool

Topics Lawsuit

2 Top Growth Stocks to Buy Right Now Without Any Hesitation ↗

July 24, 2026

There are plenty of reasons to love these companies.

Via The Motley Fool

3 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now ↗

July 23, 2026

With yields like this, these undervalued tickers aren't apt to remain this cheap forever.

Via The Motley Fool

Topics Lawsuit

Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks

July 23, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how branded pharmaceutical...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Which Healthcare ETF Is the Better Buy: Vanguard's VHT or Fidelity's FHLC? ↗

July 23, 2026

One basis point separates these two healthcare funds. Here is why the bigger decision is whether to own healthcare at all.

Via The Motley Fool

Topics ETFs

iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026? ↗

July 23, 2026

VanEck's concentrated biotech portfolio surged 30.8% in one year but endured a 39.9% drawdown. iShares offers steadier global healthcare exposure with a 1.5% dividend yield.

Via The Motley Fool

Topics ETFs

There's A Hidden Gem In Eli Lilly's Weight-Loss News — And It Could Slam Compounders ↗

July 23, 2026

Eli Lilly said Thursday it will delay filing for FDA approval of its next-gen weight-loss drug, retatrutide, until the first quarter.

Via Investor's Business Daily

Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know. ↗

July 23, 2026

Lilly's purchase of AtaiBeckley is yet another strategic move in its bid to diversify its pipeline.

Via The Motley Fool

Which Is the Better Healthcare ETF: First Trust's High-Conviction FBT or Vanguard's Low-Cost VHT? ↗

July 23, 2026

FBT surged 51.6% in one year but carries higher risk and costs. VHT offers broader diversification at a fraction of the expense ratio.

Via The Motley Fool

Topics ETFs

Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB? ↗

July 23, 2026

IBB delivered 44% returns in one year but swung 40% lower at its worst. IXJ grew steadily with half the volatility and a 1.5% dividend yield.

Via The Motley Fool

Topics ETFs

Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ ↗

July 23, 2026

The VanEck Pharmaceutical ETF (PPH) gives investors a concentrated way to own major drugmakers, while the iShares Global Healthcare ETF (IXJ) spreads exposure across the wider healthcare sector. The...

Via The Motley Fool

Topics ETFs

Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF? ↗

July 22, 2026

IHE delivered stronger 5-year returns, but VHT's 0.09% expense ratio and 411 holdings offer broader diversification at lower cost.

Via The Motley Fool

Topics ETFs

Is the iShares Healthcare ETF or the Invesco Nasdaq Biotech ETF the Better Bet for Investors in 2026? ↗

July 22, 2026

One offers global diversification and higher income; the other delivers focused biotech exposure with lower costs and stronger recent gains.

Via The Motley Fool

Topics ETFs

As Healthcare Rallies Is the Vanguard Health Care ETF of the Invesco Pharmaceuticals ETF the Better Fund for 2026? ↗

July 22, 2026

PJP surged 45% in one year, but VHT's lower costs and higher dividend yield appeal to long-term income investors seeking broad sector exposure.

Via The Motley Fool

Topics ETFs

Want Income for Life? Here Are 3 Stocks to Buy Now and Never Sell. ↗

July 22, 2026

A strong yield and an impressive track record of dividend growth aren't enough. The underlying business needs to be enduring.

Via The Motley Fool

Topics Economy

Insider Moves Are Sending Mixed Signals Across the Tech Sector ↗

July 22, 2026

Broadcom sees insider selling after volatile 2026 trading, while Netskope draws heavy insider buying post-earnings drop and Eli Lilly CEO David Ricks purchases Adobe shares.

Via MarketBeat

Topics Artificial Intelligence

PINK vs. IXJ: Which Health Care ETF Is the Better Buy for Investors? ↗

July 22, 2026

PINK has stronger one-year and three-year returns, while IXJ offers lower costs and a higher dividend yield.

Via The Motley Fool

Topics ETFs

"Deceptive Advertising!" Claims Novo Nordisk in Explosive New GLP-1 Lawsuit Against Eli Lilly. Here's What That Means for Both Stocks. ↗

July 21, 2026

Novo Nordisk is also demanding that Eli Lilly pull its ads and pay damages.

Via The Motley Fool

Topics Lawsuit

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.